Conditions: Anemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 161
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.

Detailed description:

Arms:
arm 1: 15 mg/kg up to a maximum of 750 mg at 100 mg per minute weekly to a maximum cumulative dose of 2,250 mg. arm 2: As determined by the investigator to a maximum cumulative dose of 2,250 mg.

Interventions: intervention 1: Ferric Carboxymaltose intervention 2: Iron Dextran
Intervention descriptions: intervention 1: 15 mg/kg up to a maximum of 750 mg at 100 mg per minute weekly to a maximum cumulative dose of 2,250 mg. intervention 2: As determined by the investigator to a maximum cumulative dose of 2,250 mg.

Protocol document: